Literature DB >> 8354080

Neutralization of animal viruses.

N J Dimmock1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8354080     DOI: 10.1007/978-3-642-77849-0

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  47 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

Authors:  M J Edwards; N J Dimmock
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 4.  Diversity of antibody-mediated immunity at the mucosal barrier.

Authors:  J P Bouvet; V A Fischetti
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.

Authors:  Juan Ernesto Ludert; Marie Christine Ruiz; Carlos Hidalgo; Ferdinando Liprandi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Valency of antibody binding to enveloped virus particles as determined by surface plasmon resonance.

Authors:  Sam A Hardy; Nigel J Dimmock
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Judging a virus by its cover.

Authors:  Eva Szomolanyi-Tsuda; Raymond M Welsh
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.

Authors:  Carole E Harbison; Wendy S Weichert; Brittney L Gurda; John A Chiorini; Mavis Agbandje-McKenna; Colin R Parrish
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

9.  Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor.

Authors:  Hanna Dreja; Laurent Gros; Sylvie Villard; Estanislao Bachrach; Anna Oates; Claude Granier; Thierry Chardes; Jean-Claude Mani; Marc Piechaczyk; Mireia Pelegrin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.

Authors:  J E Crowe; B R Murphy; R M Chanock; R A Williamson; C F Barbas; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.